HomeCompareSHPMF vs EQR

SHPMF vs EQR: Dividend Comparison 2026

SHPMF yields 3.81% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHPMF wins by $1402.75M in total portfolio value
10 years
SHPMF
SHPMF
● Live price
3.81%
Share price
$1.46
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1402.80M
Annual income
$1,335,511,443.90
Full SHPMF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SHPMF vs EQR

📍 SHPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHPMFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHPMF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHPMF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHPMF
Annual income on $10K today (after 15% tax)
$324.09/yr
After 10yr DRIP, annual income (after tax)
$1,135,184,727.32/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SHPMF beats the other by $1,135,180,073.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHPMF + EQR for your $10,000?

SHPMF: 50%EQR: 50%
100% EQR50/50100% SHPMF
Portfolio after 10yr
$701.42M
Annual income
$667,758,459.75/yr
Blended yield
95.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SHPMF
No analyst data
Altman Z
2.0
Piotroski
5/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHPMF buys
0
EQR buys
0
No recent congressional trades found for SHPMF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHPMFEQR
Forward yield3.81%5.87%
Annual dividend / share$0.06$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$1402.80M$47.8K
Annual income after 10y$1,335,511,443.90$5,475.61
Total dividends collected$1397.96M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SHPMF vs EQR ($10,000, DRIP)

YearSHPMF PortfolioSHPMF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$11,463$762.55$11,380$679.82+$83.00SHPMF
2$13,899$1,633.80$13,014$837.25+$885.00SHPMF
3$18,575$3,702.87$14,961$1,036.20+$3.6KSHPMF
4$29,124$9,249.68$17,297$1,289.22+$11.8KSHPMF
5$58,272$27,108.94$20,121$1,613.15+$38.2KSHPMF
6$163,733$101,382.29$23,561$2,030.84+$140.2KSHPMF
7$707,653$532,457.85$27,783$2,573.54+$679.9KSHPMF
8$5,058,632$4,301,444.15$33,013$3,284.39+$5.03MSHPMF
9$62,887,016$57,474,279.06$39,547$4,223.51+$62.85MSHPMF
10$1,402,800,551$1,335,511,443.90$47,791$5,475.61+$1402.75MSHPMF

SHPMF vs EQR: Complete Analysis 2026

SHPMFStock

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Full SHPMF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SHPMF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHPMF vs SCHDSHPMF vs JEPISHPMF vs OSHPMF vs KOSHPMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.